drugset / Trial / NCT01283724

Visanne Study to Assess Safety in Adolescents

NCT01283724

Phase 2 Completed 111 enrolled Bayer
NaSingle-groupOpen-labelTreatment

Summary

A clinical trial which was designed to demonstrate the safety and efficacy of Visanne (approved in endometriosis for adults) in the adolescent population.

Timeline

Start
2011-03
Primary completion
2013-03
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dienogest Small molecule 2 mg Oral

Indications